• FDA Approves Enzalutamide for Nonmetastatic Prostate Cancer

    4 monthes ago - By Medscape

    The oral therapy becomes the second androgen receptor-targeting therapy to be approved for use in this earlier disease setting.
    FDA Approvals
    Read more ...